Low profile thoracic aortic endograft device reduces complications and expands patient pool
Study finds up to 24 percent of esophagectomy patients can develop VTE post-operatively
2 May 2021Nurses, doctor help ‘lucky’ mom who gave birth on flight
3 May 2021Low profile thoracic aortic endograft device reduces complications and expands patient pool
Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a new, low-profile thoracic aortic endograft is safe and effective in the treatment of descending thoracic aortic aneurysm or penetrating atherosclerotic ulcer (PAU) diseases. A multi-disciplinary team, led by both cardiac and vascular surgeons as co-investigators, conducted the study in 36 centers in the United States and Japan, enrolling patients between 2016 and 2019.
